-
Easton Dermatology Associates Is First in Talbot County to Offer
Nonsurgical Treatment for Common Skin Cancer
BURR RIDGE, Ill., March 30, 2026 -- SkinCure Oncology, the industry leader in providing a comprehensive cancer center model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer (NMSC), presented to dermatology patients and professionals as the GentleCure Experience℠, today announced its first availability in Tablot County, Maryland, at Easton Dermatology Associates.
Image-Guided SRT is the only treatment for nonmelanoma skin cancer (basal and squamous cell carcinoma) that uses ultrasound imaging to help clinicians direct low-level x-rays to targeted areas of the skin, killing cancer cells. For patients treated with Image-Guided SRT, the cure rate is similar to Mohs surgery, which is also offered at the practice, but without the need for surgery or subsequent reconstruction.
Dr. Michael A. Del Torto of Easton Dermatology Associates noted, “More than 400 individuals in Talbot County and 44,000 state-wide are expected to be diagnosed with nonmelanoma skin cancer this year alone. We know that sun exposure is the main cause of this type of cancer, but there are other factors as well. For those who have been diagnosed with nonmelanoma skin cancer, we now offer a nonsurgical treatment option, and we are proud to be the first practice in the region to offer it.”
Added Dr. Donald Stranahan, “More people are diagnosed with skin cancer each year in the U.S. than all other cancers combined, and at least 1 in 5 Americans will develop skin cancer by the age of 70. Further, the incidence of skin cancer is rising faster than that of any other cancer. Everyone should see a dermatologist for an annual skin checkup and discuss treatment options to assure long-term health.”
Kerwin Brandt, chief executive officer of Chicago-based SkinCure Oncology, said, “We are delighted to partner with Easton Dermatology Associates to offer this highly effective, noninvasive treatment option for their patients. It is critical that patients everywhere have the choice of treating their nonmelanoma skin cancer without surgery.”
About SkinCure Oncology
SkinCure Oncology is the industry leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT), the most advanced nonsurgical treatment for common skin cancer. The company partners with quality-focused dermatologists, Mohs surgeons and other physicians to bring cancer center-level radiation therapy treatment to private practices. Presented to patients as the GentleCure Experience℠, Image-Guided SRT is available from some 500 physicians nationwide, with well more than 140,000 patients having been treated. Learn more about the company at SkinCureOncology.com, and visit GentleCure.com for helpful consumer and patient information.
